Paroxysmal Nocturnal Hemoglobinuria and Related Disorders : Molecular Aspects of Pathogenesis /
Few publications focus on the mysterious, genetically acquired disease paroxysmal nocturnal hemoglobinuria (PNH) and the related "intractable" disorders-aplastic anemia and myelodysplastic syndromes. Now, however, the latest understanding of the clinical and molecular genetic aspects of PN...
| Main Author: | |
|---|---|
| Corporate Author: | |
| Other Authors: | |
| Format: | eBook |
| Language: | English |
| Published: |
Tokyo :
Springer Japan,
2003.
|
| Subjects: | |
| Online Access: | Connect to the full text of this electronic book |
Table of Contents:
- From the contents: I. Overview of PNH: 1. An Overview of PNH; Molecular Genetics. 2. An Overview of the Development of Specific Inhibitors of Complement: Opportunities for Therapy of PNH
- II. Pathogenesis and Animal Models of PNH: 3. Mice with Blood Cells Deficient in GPI-Linked Proteins - the Generation of a Murine Model to Investigate the Pathogenesis and Pathophysiology of PNH. 4. A multistep Model for the Pathogenesis and Evolution of PNH. 5. Some New Viewpoints of Molecular Pathogenesis in Paroxysmal Nocturnal Hemoglobinuria (PNH)
- III. Clinical Pathology and Natural History of PNH: 6. Paroxysmal Nocturnal Hemoglobinuria: History and Pathology. 7. Long-Term Outcome in PNH; the French Society of Hematology Experience
- IV. Mechanism of Clonal Expansion in PNH: 8. PNH Clone is Less Susceptible to Killing by NK Cells. 9. The Role of Lymphoid Cell Clones in the Pathogenesis of PNH. 10. A Possible Intrinsic Mechanism for Clonal Expansion of PNH Abnormal Cells
- V. PNH Clones under Bone Marrow Failure: 11. Clinical Significance of Increased PNH-Type Cells in the Peripheral Blood of Patients with Aplastic Anemia and Refractory Anemia. 12. Incidence and Clinical Significance of PNH Clone in Myelodysplastic Syndromes (MDS). 13. The Enigmatic Relationship of Paroxysmal Noctural Hemoglobinuria and Acquired Aplastic Anemia
- VI. PNH, Aplastic Anemia, Myelodysplastic Syndromes: (1) Pathology: 14. Does PNH Ever Arise De Novo? 15. Telomeres in Myelodysplastic Syndromes. 16. Immunosuppression in Aplastic Anemia. (2) Clinical Aspects: 17. MDS/Leukemia and PNH After Immunosuppressive Therapy for Severe Aplastic Anemia. 18. Stem Cell Transplantation in Aplastic Anemia and PNH: Similarities and Diversities
- VII. Related Topics.